Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • OKLO vs MRNA✓SelectedUSD · MRNAOKLO vs MRNA performance historyLatest closeAs of-4.75%11/20
Stock and ETF performance explorer

OKLO vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+99.7%
MRNA return
-27.3%
Excess return
+127.0%
Maximum drawdown
-89.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.8%-2.2%-2.6%-4.5%
7D-17.0%-12.7%-4.3%-15.9%
30D-28.4%-20.7%-7.7%-26.9%
3M-52.4%+46.3%-98.6%-54.1%
6M-68.3%+305.2%-373.5%-74.5%
YTD-72.3%+561.2%-633.6%-79.3%
1Y-77.4%+772.1%-849.5%-83.8%
3Y+92.3%+147.0%-54.6%+53.9%
All+99.7%-27.3%+127.0%+60.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling